RAC Audit Identifies Overpayments for Billing Incorrect DME Codes
RAC Region C contractor Connolly posted 2 automated reviews for DME providers on April 8, 2014, regarding Mechanical In-exsufflation Devices, High Frequency Chest Wall Oscillation Devices, and Urological Supplies. Per the contractor’s description of these issues, overpayments were identified where ICD-9-CM coding was not in accordance with billing requirements outlined in Local Coverage Determinations (LCD) for DME devices.
Mechanical In-Exsufflation
HCPCS CODES
Group 1 Codes:
A7020 |
INTERFACE FOR COUGH STIMULATING DEVICE, INCLUDES ALL COMPONENTS, REPLACEMENT ONLY |
E0482 |
COUGH STIMULATING DEVICE, ALTERNATING POSITIVE AND NEGATIVE AIRWAY PRESSURE |
ICD-9-CM Codes that Support Medical Necessity
Group 1 Paragraph: The presence of an ICD-9-CM code listed in this section is not sufficient by itself to assure coverage. Refer to the section on “Coverage Indications, Limitations and/or Medical Necessity” for other coverage criteria and payment information.
Group 1 Codes:
138 |
LATE EFFECTS OF ACUTE POLIOMYELITIS |
335.0 - 335.9 |
WERDNIG-HOFFMANN DISEASE - ANTERIOR HORN CELL DISEASE UNSPECIFIED |
340 |
MULTIPLE SCLEROSIS |
344.00 - 344.09 |
QUADRIPLEGIA UNSPECIFIED - OTHER QUADRIPLEGIA |
359.0 |
CONGENITAL HEREDITARY MUSCULAR DYSTROPHY |
359.1 |
HEREDITARY PROGRESSIVE MUSCULAR DYSTROPHY |
359.21 |
MYOTONIC MUSCULAR DYSTROPHY |
359.71 |
INCLUSION BODY MYOSITIS |
High Chest Wall Oscillation
HCPCS CODES
Group 1 Codes:
A7025 |
HIGH FREQUENCY CHEST WALL OSCILLATION SYSTEM VEST, REPLACEMENT FOR USE WITH PATIENT OWNED EQUIPMENT, EACH |
A7026 |
HIGH FREQUENCY CHEST WALL OSCILLATION SYSTEM HOSE, REPLACEMENT FOR USE WITH PATIENT OWNED EQUIPMENT, EACH |
E0483 |
HIGH FREQUENCY CHEST WALL OSCILLATION AIR-PULSE GENERATOR SYSTEM, (INCLUDES HOSES AND VEST), EACH |
ICD-9-CM Codes that Support Medical Necessity
Group 1 Paragraph: The presence of an ICD-9 code listed in this section is not sufficient by itself to assure coverage. Refer to the section on “Coverage Indications, Limitations and/or Medical Necessity” for other coverage criteria and payment information.
Group 1 Codes:
011.50 - 011.56 |
TUBERCULOUS BRONCHIECTASIS UNSPECIFIED EXAMINATION - TUBERCULOUS BRONCHIECTASIS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF ANIMALS) |
138 |
LATE EFFECTS OF ACUTE POLIOMYELITIS |
277.00 |
CYSTIC FIBROSIS WITHOUT MECONIUM ILEUS |
277.02 |
CYSTIC FIBROSIS WITH PULMONARY MANIFESTATIONS |
277.6 |
OTHER DEFICIENCIES OF CIRCULATING ENZYMES |
335.0 - 335.9 |
WERDNIG-HOFFMANN DISEASE - ANTERIOR HORN CELL DISEASE UNSPECIFIED |
340 |
MULTIPLE SCLEROSIS |
344.00 - 344.09 |
QUADRIPLEGIA UNSPECIFIED - OTHER QUADRIPLEGIA |
359.0 |
CONGENITAL HEREDITARY MUSCULAR DYSTROPHY |
359.1 |
HEREDITARY PROGRESSIVE MUSCULAR DYSTROPHY |
359.21 - 359.29 |
MYOTONIC MUSCULAR DYSTROPHY - OTHER SPECIFIED MYOTONIC DISORDER |
359.4 - 359.6 |
TOXIC MYOPATHY - SYMPTOMATIC INFLAMMATORY MYOPATHY IN DISEASES CLASSIFIED ELSEWHERE |
359.89 |
OTHER MYOPATHIES |
494.0 |
BRONCHIECTASIS WITHOUT ACUTE EXACERBATION |
494.1 |
BRONCHIECTASIS WITH ACUTE EXACERBATION |
519.4 |
DISORDERS OF DIAPHRAGM |
748.61 |
CONGENITAL BRONCHIECTASIS |
Headquartered in the Chicago area, Context has more than 25 years of experience in software & data product development. Our solutions impact more than 4,000 clients & tens of millions of lives globally. Context’s solutions have been developed to address the industry challenges currently faced by healthcare payers & providers
Our online real-time claim editing software contains millions of edit combinations identifying inaccurate billing practices, regulatory requirements & other errors. Delivered in a software as a service model, our editing is easily implemented.
Our 100+ data products are a one-stop shop for your data & coding challenges, & provide the code sets required for accurate claim processing. Our proprietary ICD-10 solutions include crosswalk databases & our server-based ICD-10 compliant coding software.
Want more info on RAC audits? RAC Drill Down - Cetuximab & Medical Necessity